Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Proteome Res ; 22(10): 3348-3359, 2023 10 06.
Article in English | MEDLINE | ID: mdl-37676068

ABSTRACT

Cognitive flexibility is a crucial ability in humans that can be affected by chronic methamphetamine (METH) addiction. The present study aimed to elucidate the mechanisms underlying cognitive impairment in mice chronically administered METH via an oral self-administration method. Further, the effect of melatonin treatment on recovery of METH-induced cognitive impairment was also investigated. Cognitive performance of the mice was assessed using an attentional set shift task (ASST), and possible underlying neurotoxic mechanisms were investigated by proteomic and western blot analysis of the prefrontal cortex (PFC). The results showed that mice-administered METH for 21 consecutive days exhibited poor cognitive performance compared to controls. Cognitive deficit in mice partly recovered after METH withdrawal. In addition, mice treated with melatonin during METH withdrawal showed a higher cognitive recovery than vehicle-treated METH withdrawal mice. Proteomic and western blot analysis revealed that METH self-administration increased neurotoxic markers, including disruption to the regulation of mitochondrial function, mitophagy, and decreased synaptic plasticity. Treatment with melatonin during withdrawal restored METH-induced mitochondria and synaptic impairments. These findings suggest that METH-induced neurotoxicity partly depends on mitochondrial dysfunction leading to autophagy-dependent cell death and that the recovery of neurological impairments may be enhanced by melatonin treatment during the withdrawal period.


Subject(s)
Cognitive Dysfunction , Melatonin , Methamphetamine , Substance Withdrawal Syndrome , Humans , Mice , Animals , Methamphetamine/toxicity , Melatonin/pharmacology , Proteomics , Cognitive Dysfunction/chemically induced
2.
Neurochem Int ; 148: 105083, 2021 09.
Article in English | MEDLINE | ID: mdl-34052298

ABSTRACT

Chronic stress is a risk factor for the development of psychiatric illnesses through impairment of the ability to appropriately regulate physiological and behavioral responses, but the molecular events that lead to damage of hippocampal neurons remain unclear. The medicinal herb Spilanthes acmella Murr. has been used as a traditional medicine for various diseases and its extracts exhibit antioxidant activity. The present study explored the molecular signals of mitochondrial dynamics and investigated the beneficial effects of S. acmella Murr. An ethyl acetate extract of this plant was used to assess mitochondrial dynamics in response to chronic restraint stress (CRS) in male Sprague-Dawley rats. The results demonstrated that the S. acmella Murr. extract reduced the expression of mitochondrial fission protein but induced HSP60, MnSOD and ATPsynthase in the hippocampus of the CRS rats. In addition, S. acmella Murr. extract reversed depressive symptoms in the forced swim test. Our findings suggested that S. acmella Murr. extract provides a potential treatment of chronic stress, and that the mechanism is associated with the alleviation of neuronal injury and maintenance of mitochondrial function.


Subject(s)
Asteraceae/chemistry , Mitochondria/drug effects , Plant Extracts/therapeutic use , Stress, Psychological/drug therapy , Animals , Antioxidants , Behavior, Animal/drug effects , Chaperonin 60/biosynthesis , Chaperonin 60/genetics , Chronic Disease , Cognition/drug effects , Depression/drug therapy , Depression/psychology , Hippocampus/drug effects , Hippocampus/metabolism , Male , Mitochondria/metabolism , Mitochondrial Dynamics/drug effects , Mitochondrial Proteins/biosynthesis , Mitochondrial Proteins/genetics , Plants, Medicinal , Rats , Rats, Sprague-Dawley , Restraint, Physical
SELECTION OF CITATIONS
SEARCH DETAIL
...